| | REACH - What Happened and Why? The Only Planet Guide to the |
| | 2,52 | | MB | Secrets of Chemicals Policy in the EU |
| | 149 | | stron |
| | 2309 | | ID | Greens/European Free Alliance in European Parliament |
| | 2004 | | rok |
| | CONTENTS |
| | Foreword, by Joseph DiGangi 9 |
| | PART ONE: CHEMICALS |
| | Facts About the Chemicals Industry 13 |
| | GLOBAL INDUSTRY |
| | Overview 14 |
| | Production 14 |
| | Outlook 14 |
| | Globalisation 14 |
| | Mergers and Acquisitions 15 |
| | Organisation 15 |
| | EUROPEAN INDUSTRY |
| | Overview 15 |
| | Production 16 |
| | Outlook 16 |
| | Mergers and Acquisitions 17 |
| | Organisation 17 |
| | SUMMARY 18 |
| | Map of the Chemicals Industry in Europe 19 |
| | Defining the Chemicals Industry 20 |
| | POLLUTION |
| | Overview 21 |
| | Rainwater 21 |
| | Persistence 21 |
| | The Arctic 22 |
| | Persistent Organic Pollutants - POPs 22 |
| | Mountains 23 |
| | Fish 23 |
| | Dioxin in Fish 23 |
| | Bioaccumulation 24 |
| | Vegetables, Fruit and Oil 24 |
| | House Dust 24 |
| | Human Blood and Tissue 24 |
| | Human Breast Milk 25 |
| | SUMMARY 25 |
| | EFFECTS |
| | Overview 26 |
| | Exposure Types 26 |
| | Acute Exposure 26 |
| | Chronic Exposure 26 |
| | Causality 26 |
| | Causality and Association 27 |
| | ENVIRONMENT AND WILDLIFE |
| | Overview 27 |
| | Climate Change 27 |
| | Ozone Depletion 28 |
| | Loss of biodiversity 28 |
| | Major accidents 28 |
| | Tropospheric ozone 28 |
| | Management of Freshwater 29 |
| | Forest Degradation 29 |
| | Coastal Threats 29 |
| | Waste 29 |
| | Urban Stress 30 |
| | Chemical Risk 30 |
| | HUMAN HEALTH |
| | Overview 30 |
| | Some Numbers 30 |
| | Cancer 31 |
| | Reproduction 32 |
| | Allergies and Asthma 32 |
| | Economic Costs 33 |
| | SUMMARY 33 |
| | Chemicals in the Environment 21 |
| | Effects of Chemicals 26 |
| | Summary of Part One 34 |
| | RISK MANAGEMENT |
| | Overview 49 |
| | Existing and New Substances 49 |
| | The EU Model 49 |
| | Introducing Precaution 50 |
| | The Four Elements of Risk Assessment 50 |
| | Liability 51 |
| | Responsibility 51 |
| | Summary 51 |
| | CURRENT REGULATION |
| | Overview 51 |
| | Data Gaps Regarding High Production |
| | Volume Chemicals in the OECD and EU 52 |
| | The Directive on Classification |
| | and Labelling of Chemicals (1967) 52 |
| | The Directive on Restrictions |
| | of Certain Substances (1976) 53 |
| | Amendment Concerning |
| | Existing Substances (1979) 53 |
| | The Directive on Classification |
| | and labelling of Preparations (1988) 53 |
| | The Regulation on Evaluation of |
| | Existing Substances (1993) 54 |
| | IINITIATIVES FOR INCREASED SAFETY |
| | Overview 54 |
| | Existing and New Substances 55 |
| | Proposal for a Policy 55 |
| | Council Requests Review 56 |
| | Call by Parliament for Action on |
| | Endocrine Disrupters 56 |
| | Launches of Global Initiatives by Industry 56 |
| | Commission Review 57 |
| | Regulating Endocrine Disrupters 57 |
| | Council Feedback on Review 58 |
| | Stakeholder Brainstorm 58 |
| | Council Asks for Precaution 58 |
| | Industry Increases Efforts to |
| | Create Confidence 58 |
| | Council Adopts Conclusions 59 |
| | Commission Presents |
| | Fundamental Elements 59 |
| | Commission Review 59 |
| | The Precautionary Principle 60 |
| | Cefic Launch Stakeholder Dialogue 60 |
| | Communication on Precautionary Principle 60 |
| | Industry Calls for Partnership 60 |
| | Commission Presents Progress 60 |
| | Industry and Commission Stress |
| | Growth and Innovation 61 |
| | Highlights 61 |
| | SUMMARY 61 |
| | PART TWO: POLITICS |
| | BRIEF HISTORY |
| | Prehistoric 36 |
| | Early Industrialism 36 |
| | 1800- 36 |
| | The First Conventions 36 |
| | The Petro-chemistry Boom 36 |
| | Post World War ll 37 |
| | Time for Treaties 37 |
| | Loss of Leadership 37 |
| | GLOBAL INSTRUMENTS |
| | Some Definitions 38 |
| | UN Instruments Concerning Chemicals 39 |
| | IFCS 42 |
| | OECD 43 |
| | The World Bank 44 |
| | World Trade Organisation (WTO) 44 |
| | REGIONAL INSTRUMENTS |
| | United Nations 44 |
| | Other Instruments 45 |
| | CORPORATE INITIATIVES |
| | Responsible Care 47 |
| | The HPV Initiative 47 |
| | The Long-range Research Initiative 48 |
| | HERA 48 |
| | SUMMARY 48 |
| | European Chemicals Policy 49 |
| | International Chemicals Policy 35 |
| | THE WHITE PAPER |